Free Trial

Star Equity (STRR) Competitors

Star Equity logo
$3.17 +0.07 (+2.26%)
(As of 11/15/2024 ET)

STRR vs. CHFS, CODX, ALUR, SURG, POCI, IRIX, DRIO, BSGM, MDAI, and XAIR

Should you be buying Star Equity stock or one of its competitors? The main competitors of Star Equity include Nuwellis (CHFS), Co-Diagnostics (CODX), Allurion Technologies (ALUR), SurgePays (SURG), Precision Optics (POCI), IRIDEX (IRIX), DarioHealth (DRIO), BioSig Technologies (BSGM), Spectral AI (MDAI), and Beyond Air (XAIR).

Star Equity vs.

Nuwellis (NASDAQ:CHFS) and Star Equity (NASDAQ:STRR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.

Nuwellis has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.1, meaning that its stock price is 90% less volatile than the S&P 500.

Star Equity has a net margin of -14.65% compared to Nuwellis' net margin of -254.26%. Star Equity's return on equity of -5.74% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-254.26% -173.61% -131.01%
Star Equity -14.65%-5.74%-3.34%

65.1% of Nuwellis shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 0.6% of Nuwellis shares are owned by company insiders. Comparatively, 33.5% of Star Equity shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Star Equity has higher revenue and earnings than Nuwellis. Star Equity is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$5.51M1.97-$18.11M-$279.28-0.01
Star Equity$45.78M0.22$25.13M-$2.79-1.14

Nuwellis received 321 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 69.53% of users gave Nuwellis an outperform vote.

CompanyUnderperformOutperform
NuwellisOutperform Votes
324
69.53%
Underperform Votes
142
30.47%
Star EquityOutperform Votes
3
100.00%
Underperform Votes
No Votes

In the previous week, Star Equity had 4 more articles in the media than Nuwellis. MarketBeat recorded 4 mentions for Star Equity and 0 mentions for Nuwellis. Star Equity's average media sentiment score of 0.70 beat Nuwellis' score of 0.00 indicating that Star Equity is being referred to more favorably in the news media.

Company Overall Sentiment
Nuwellis Neutral
Star Equity Positive

Summary

Star Equity beats Nuwellis on 10 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STRR vs. The Competition

MetricStar EquityElectromedical equipment IndustryMulti-Sector SectorNASDAQ Exchange
Market Cap$10.24M$3.61B$16.86B$8.74B
Dividend YieldN/A1.65%3.68%4.08%
P/E Ratio-1.1411.469.9213.57
Price / Sales0.2299.252.8087.67
Price / Cash8.6946.1712.9035.24
Price / Book0.223.802.215.93
Net Income$25.13M$92.21M$868.86M$225.73M
7 Day Performance-11.74%-2.39%-4.14%-1.34%
1 Month Performance-18.72%13.84%-6.67%1.15%
1 Year Performance-35.88%26.34%-4.19%24.02%

Star Equity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STRR
Star Equity
2.1789 of 5 stars
$3.17
+2.3%
N/A-32.5%$10.24M$45.78M-1.14171Upcoming Earnings
News Coverage
CHFS
Nuwellis
N/A$1.95
+1.0%
N/A+185.7%$11.77M$5.51M-0.0466Gap Up
CODX
Co-Diagnostics
4.4008 of 5 stars
$1.10
-0.9%
N/A-24.0%$35.12M$9.14M-0.80100Short Interest ↓
Analyst Revision
ALUR
Allurion Technologies
2.1245 of 5 stars
$0.39
-24.9%
N/A-91.9%$33.67M$47.59M-0.45501Analyst Downgrade
Analyst Revision
News Coverage
SURG
SurgePays
3.8213 of 5 stars
$1.63
-4.7%
N/A-71.4%$32.19M$137.14M-1.4422Earnings Report
Short Interest ↓
News Coverage
Gap Down
POCI
Precision Optics
0.9129 of 5 stars
$4.73
-4.4%
N/A-12.1%$30.04M$19.10M-9.6580Short Interest ↓
News Coverage
Gap Up
High Trading Volume
IRIX
IRIDEX
0.7217 of 5 stars
$1.77
-6.3%
N/A-15.5%$29.22M$51.87M-2.64120Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
High Trading Volume
DRIO
DarioHealth
2.75 of 5 stars
$0.81
-6.9%
N/A-23.7%$27.49M$20.35M-0.86200Positive News
Gap Down
BSGM
BioSig Technologies
N/A$1.58
-9.7%
N/A-48.6%$27.07M$40,000.000.0050News Coverage
Gap Up
MDAI
Spectral AI
2.8473 of 5 stars
$1.45
+4.3%
N/A-48.1%$26.84M$22.53M-2.2378Positive News
Gap Up
XAIR
Beyond Air
4.4909 of 5 stars
$0.53
+10.4%
N/A-68.2%$25.01M$1.78M-0.3870Earnings Report
Analyst Revision
News Coverage

Related Companies and Tools


This page (NASDAQ:STRR) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners